0001062993-23-018421.txt : 20230922 0001062993-23-018421.hdr.sgml : 20230922 20230922183939 ACCESSION NUMBER: 0001062993-23-018421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230920 FILED AS OF DATE: 20230922 DATE AS OF CHANGE: 20230922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lapidus Stanley CENTRAL INDEX KEY: 0001678195 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40901 FILM NUMBER: 231272730 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucid Diagnostics Inc. CENTRAL INDEX KEY: 0001799011 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 825488042 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212 949 4319 MAIL ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-09-20 0001799011 Lucid Diagnostics Inc. LUCD 0001678195 Lapidus Stanley 360 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10017 1 0 0 0 0 Common stock 2023-09-20 4 S 0 3405 1.45 D 132051 D Common stock 2023-09-20 4 S 0 412 1.44 D 131639 D Common stock 2023-09-21 4 S 0 100 1.44 D 131539 D Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. /s/ Michael A. Gordon, by power of attorney 2023-09-22